Pharmacogenetic-Based Interactions between Nutraceuticals and Angiogenesis Inhibitors

Pharmacogenetic-Based Interactions between Nutraceuticals and Angiogenesis Inhibitors

<b>Background:</b> Angiogenesis inhibitors (AIs) have become established as an effective cancer treatment. Whereas their interactions with antineoplastic drugs have extensively been investigated, little is known of the effect of their co-administration with nutraceuticals/dietary supplem...

Full description

Bibliographic Details
Main Authors: Raffaele Di Francia, Massimiliano Berretta, Giulio Benincasa, Alfredo D’Avino, Sergio Facchini, Domenico Costagliola, Paola Rossi
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Cells
Subjects:
neoangiogenesis
complementary and alternative medicines (CAMs)
targeted treatment
pharmacogenomics
cytochrome P450 polymorphisms
nutraceuticals
dietary supplements
Online Access:https://www.mdpi.com/2073-4409/8/6/522

Similar Items

Similar Items